ARTICLE | Company News
FDA wants pediatric ADHD data from Shire
October 10, 2014 2:29 AM UTC
FDA requested additional pediatric data from Shire plc (LSE:SHP; NASDAQ:SHPG) to support resubmission of an NDA for SHP465 triple-bead mixed amphetamine salts (MAS) to treat ADHD in adults. ...